Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Accrued Liabilities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Accrued Liabilities
CHf6.7m
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Accrued Liabilities
$39.1m
CAGR 3-Years
48%
CAGR 5-Years
51%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accrued Liabilities
CHf11.9m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accrued Liabilities
$64.1m
CAGR 3-Years
-7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Accrued Liabilities
CHf12m
CAGR 3-Years
-22%
CAGR 5-Years
-9%
CAGR 10-Years
5%
Kuros Biosciences AG
SIX:KURN
Accrued Liabilities
CHf8.7m
CAGR 3-Years
49%
CAGR 5-Years
37%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Accrued Liabilities?
Accrued Liabilities
6.7m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Accrued Liabilities amounts to 6.7m CHF.

What is Molecular Partners AG's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-1%

Over the last year, the Accrued Liabilities growth was 14%. The average annual Accrued Liabilities growth rates for Molecular Partners AG have been -12% over the past three years , -1% over the past five years .

Back to Top